Cargando…
Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series
OBJECTIVES: A recent study suggests that Multisystem Inflammatory Syndrome in Children (MIS-C) is triggered by gastrointestinal breach of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral particles from the gut lumen into systemic circulation. The virus remains in the gut weeks to m...
Autores principales: | Yonker, Lael M., Swank, Zoe, Gilboa, Tal, Senussi, Yasmeen, Kenyon, Victoria, Papadakis, Lena, Boribong, Brittany P., Carroll, Ryan W., Walt, David R., Fasano, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860335/ https://www.ncbi.nlm.nih.gov/pubmed/35211683 http://dx.doi.org/10.1097/CCE.0000000000000641 |
Ejemplares similares
-
Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation
por: Di Micco, Simone, et al.
Publicado: (2021) -
The Heart of the Problem in Multisystem Inflammatory Syndrome in Children
por: Boribong, Brittany P., et al.
Publicado: (2021) -
In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate
por: Di Micco, Simone, et al.
Publicado: (2021) -
Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
por: Burns, Madeleine D., et al.
Publicado: (2023) -
Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2
por: Di Micco, Simone, et al.
Publicado: (2022)